Difference between revisions of "Naloxone"
From WikiAnesthesia
Chris Rishel (talk | contribs) |
Chris Rishel (talk | contribs) |
||
| Line 7: | Line 7: | ||
| contraindications = | | contraindications = | ||
| routes = Intramuscular, Intranasal, Intravenous | | routes = Intramuscular, Intranasal, Intravenous | ||
| dosage = 0. | | dosage = Delayed emergence: | ||
* 20-200 mcg IV q2-3m | |||
Opioid overdose: | |||
* 0.1-2 mg IV/IM/ETT q2-3m | |||
| mechanism = Opioid-receptor antagonism | | mechanism = Opioid-receptor antagonism | ||
| adverse_effects = Acute opioid withdrawal, hypotension, arrhythmias, pulmonary edema | | adverse_effects = Acute opioid withdrawal, hypotension, arrhythmias, pulmonary edema | ||
Revision as of 01:19, 12 November 2021
Naloxone
| Trade names |
Narcan |
|---|---|
 | |
| Clinical data | |
| Uses |
Reversal of opioid agonism |
| Routes of administration |
Intramuscular, Intranasal, Intravenous |
| Dosage |
Delayed emergence:
Opioid overdose:
|
| Pharmacodynamics | |
| Mechanism of action |
Opioid-receptor antagonism |
| Adverse effects |
Acute opioid withdrawal, hypotension, arrhythmias, pulmonary edema |
| Pharmacokinetics | |
| Onset of action |
1-2 minutes (IV) |
| Duration of action |
30-60 minutes |
| Metabolism |
Hepatic |
| Elimination half-life |
1-1.5 hours |
| Physical and chemical data | |
| Formula |
C19H21NO4 |
| Molar mass |
327.380 g/mol |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Naloxone is an opioid-receptor antagonist which is used for the reversal of opioid overdose.
Uses
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
Adverse effects
Pharmacokinetics
Chemistry and formulation
History
References
Top contributors: Chris Rishel